PGIM India Healthcare Fund - Direct (G): NFO Details

PGIM India Healthcare Fund - Direct (G) focuses on equity and equity-related securities in the healthcare and pharmaceutical industries. It provides exposure to various sub-sectors, such as healthcare services, pharmaceutical manufacturing, and more. With a flexible investment strategy aimed at generating long-term returns and actively managing risks, this fund is for those who want to capitalize on the growth potential of India’s healthcare sector while mitigating market volatility.

Details of the NFO: PGIM India Healthcare Fund - Direct (G)

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Investment Objective and Strategy

Objective:

The primary objective of the scheme is to achieve consistent returns by primarily investing in equity and equity-related securities of pharmaceutical and healthcare companies. However, it is important to note that the achievement of this investment objective is not guaranteed, and the scheme does not promise or indicate any assured returns.

Investment Strategy:

The investment strategy of PGIM India Healthcare Fund - Direct (G) is focused on equity investments in healthcare and pharmaceutical companies, combining top-down and bottom-up approaches to ensure a diversified and balanced portfolio. 

It covers a broad spectrum of sectors within the healthcare ecosystem, including services like pharmacy chains, diagnostics, hospitals, and health insurance, as well as manufacturing segments such as CRAMS, medical devices, specialty chemicals, and APIs. This diversified exposure aims to capitalize on growth opportunities across the industry. 

To mitigate risk, a portion of the corpus is allocated to debt and money market instruments, providing stability during market volatility, while derivatives are strategically utilized to hedge risks and enhance portfolio flexibility. 

The fund’s performance is benchmarked against the BSE Healthcare TRI, ensuring it aligns with the broader healthcare sector's performance and investor expectations.

Strength and Risks - PGIM India Healthcare Fund - Direct (G)

Strengths:

PGIM India Healthcare Fund - Direct (G) has a few key strengths that makes it a good option for investors.

Sector Resilience: The healthcare and pharmaceutical sectors are less sensitive to economic cycles, offering stability during market downturns. This is particularly appealing for long-term investors.

Growth Potential: India’s healthcare sector is poised for significant growth, driven by increasing healthcare spending, rising demand for pharmaceuticals, and technological advancements in medical devices and diagnostics.

Diversified Portfolio: The fund invests across multiple healthcare sub-sectors, spreading risk and capturing varied growth opportunities.

Risk Management: A disciplined approach to risk, including credit evaluation, liquidity analysis, and diversification, ensures consistent returns while safeguarding against market volatility.

Risks:

PGIM India Healthcare Fund - Direct (G) also has certain risks associated with it that investors should be aware of:

Market Volatility: Equity investments are subject to price fluctuations, which may impact short-term returns.

Liquidity Risks: Certain healthcare stocks or debt instruments may face liquidity challenges, limiting flexibility during market stress.

Regulatory Changes: The healthcare industry is heavily regulated, and sudden changes can impact the fund's performance.

Derivative Usage: While derivatives can hedge risks, they carry inherent risks like mispricing, illiquidity, or misalignment with underlying assets.

Why Invest in PGIM India Healthcare Fund - Direct (G)?

The PGIM India Healthcare Fund - Direct (G) offers an opportunity for long-term capital growth by focusing on high-potential healthcare and pharmaceutical stocks. Leveraging deep sectoral expertise, it analyzes healthcare trends and company fundamentals. The inherent resilience of the healthcare sector during economic downturns ensures steady and reliable performance, making it a prudent choice for long-term investors. 
Additionally, the fund employs rigorous risk management strategies, including portfolio diversification, liquidity monitoring, and credit quality analysis, to minimize risks while maintaining attractive returns. With the healthcare sector on a growth trajectory driven by increasing awareness, technological advancements, and supportive government policies, the fund is well-positioned to capture emerging investment opportunities.